|
SourceOne Stock Info Your one source site for
stock research |
||||||||||||
Investor Relations
What’s the buzz— message boards |
Millennium
Pharmaceuticals, Inc. MLNM Millennium Pharmaceuticals, Inc. is biopharmaceutical company
focused on discovering, developing and commercializing medicines to change
the lives of patients with cancer and inflammatory diseases. It
commercializes VELCADE for Injection, for the treatment of patients with
multiple myeloma who have received at least one prior therapy. In addition,
VELCADE is United States Food and Drug Administration, approved therapeutic
for the treatment of patients who have received at least one prior therapy
for mantle cell lymphoma, an aggressive form of non-Hodgkin’s lymphoma.
Millennium has a development pipeline of nine clinical and preclinical
product candidates in its therapeutic focus areas of cancer and inflammation,
and it has an oncology-focused discovery organization. Stock Quotes and Other InformationSearch
for Stocks: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Alphabetical
Listings by Company Name S&P
100 S&P
500 S&P
400 Dow Jones
Industrials Dow Jones Transportation Dow Jones
Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech
35 |
|
||||||||||